KYOWA PHARMACEUTICAL IND.CO.,LTD., — Sertraline Importer Profile
Pharmaceutical Importer · #5 buyer for Sertraline · $2.0M import value · 45 shipments · JAPAN · DGFT Verified
KYOWA PHARMACEUTICAL IND.CO.,LTD., is the #5 importer of Sertraline from India with $2.0M in import value and 45 verified shipments. KYOWA PHARMACEUTICAL IND.CO.,LTD., holds a 0.9% market share in Sertraline imports based in JAPAN. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.
KYOWA PHARMACEUTICAL IND.CO.,LTD., — Sertraline Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sertraline to KYOWA PHARMACEUTICAL IND.CO.,LTD.,?
Verified from 45 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LUPIN LIMITED | $2.0M | 45 | 100.0% |
KYOWA PHARMACEUTICAL IND.CO.,LTD., sources Sertraline from 1 verified Indian supplier based on 45 customs records. The primary supplier is LUPIN LIMITED accounting for 100.0% of imports.
How Does KYOWA PHARMACEUTICAL IND.CO.,LTD., Compare to Nearest Sertraline Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | GRANULES PHARMACEUTICALS INC | UNITED STATES | $2.5M | 50 | $50.0K |
| 18 | M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.4M | 74 | $31.9K |
| 5 | KYOWA PHARMACEUTICAL IND.CO.,LTD., ★ | JAPAN | $2.3M | 45 | $50.0K |
| 20 | TORRENT DO BRASIL LTDA | BRAZIL | $2.2M | 103 | $21.6K |
| 14 | GRANULES PHARMACEUTICALS, INC. | UNITED STATES | $2.0M | 41 | $50.0K |
KYOWA PHARMACEUTICAL IND.CO.,LTD., ranks #5 among 553 Sertraline importers from India. Average shipment value of $50.0K compared to the market average of $139.5K. The closest competitors by value are GRANULES PHARMACEUTICALS INC and M/S. RANBAXY FARMACEUTICA LTDA :.
Where Does KYOWA PHARMACEUTICAL IND.CO.,LTD., Import Sertraline To?
Destination countries from 45 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $2.0M | 45 | 100.0% |
KYOWA PHARMACEUTICAL IND.CO.,LTD., imports Sertraline to 1 country. The primary destination is JAPAN receiving 100.0% of shipments worth $2.0M.
What Sertraline Formulations Does KYOWA PHARMACEUTICAL IND.CO.,LTD., Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN (SERTRALINE 25MG) - 1'S | $504.1K | 12 |
| PHARMA : SERTRALINE TABLETS 25MG KYOWA J | $350.0K | 7 |
| PHARMA : SERTRALINE TABLETS 50MG KYOWA J | $300.0K | 6 |
| PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN (SERTRALINE 50MG) - 1'S | $250.0K | 5 |
| PHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN (SERTRALINE 25MG) - 1'SPCS | $215.5K | 6 |
| PHARMA : SERTRALINE TABLETS 100MG KYOWA | $150.0K | 3 |
| PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN (SERTRALINE 50MG) - 1'SPCS | $150.0K | 3 |
| PHARMA : SERTRALINE TABLETS 100MG KYOWAJAPAN (SERTRALINE 100MG) - 1'SPCS | $82.5K | 3 |
KYOWA PHARMACEUTICAL IND.CO.,LTD., imports 8 distinct Sertraline formulations from India. The top formulation is PHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN (SERTRALINE 25M with 12 shipments worth $504.1K.
Regulatory Requirements: Importing Sertraline into Japan
What KYOWA PHARMACEUTICAL IND.CO.,LTD., and other importers must comply with to import Sertraline from India
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMDA)
Approval Process for Generic Sertraline
Generic Drug Application under Japan Pharmaceutical Affairs Act. Requires dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Typical timeline: 12–24 months
GMP Requirements
Japanese GMP (J-GMP) compliance; PMDA on-site inspection of manufacturing facility
Import Licence & Documentation
Marketing Authorization Holder (MAH) must be a Japanese entity; Foreign Manufacturer Registration (Accreditation) required
Labeling & Packaging
Japanese language labeling mandatory; Japanese Pharmacopoeia compliance
Note: Japan requires Yen-denominated pricing approval (NHI drug price listing). Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available PMDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with PMDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sertraline from India and How Much Does KYOWA PHARMACEUTICAL IND.CO.,LTD., Import?
India exported $77.1M worth of Sertraline through 5,183 shipments from 218 suppliers to 88 countries, serving 553 buyers globally. KYOWA PHARMACEUTICAL IND.CO.,LTD., imports $2.0M of this total, accounting for 0.9% of India's Sertraline exports with 45 shipments from JAPAN. This is verified from 45 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for KYOWA PHARMACEUTICAL IND.CO.,LTD.,'s Sertraline Imports?
KYOWA PHARMACEUTICAL IND.CO.,LTD.,'s average Sertraline order value is $44.5K per consignment, based on 45 shipments totaling $2.0M. KYOWA PHARMACEUTICAL IND.CO.,LTD., is based in JAPAN and ranks #5 among all Sertraline importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sertraline to KYOWA PHARMACEUTICAL IND.CO.,LTD.,?
KYOWA PHARMACEUTICAL IND.CO.,LTD., sources Sertraline from 1 verified Indian supplier: LUPIN LIMITED ($2.0M, 100.0%). This is based on 45 customs records.
How Does KYOWA PHARMACEUTICAL IND.CO.,LTD., Compare to Other Sertraline Importers?
KYOWA PHARMACEUTICAL IND.CO.,LTD., ranks #5 among 553 Sertraline importers from India with a 0.9% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($17.1M), YUSEN LOGISTICS BENELUX BELGIUM ($14.1M), APL SWIFT SERVICES (MALTA) LTD., ($11.8M). KYOWA PHARMACEUTICAL IND.CO.,LTD., processed 45 shipments from JAPAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sertraline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sertraline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: KYOWA PHARMACEUTICAL IND.CO.,LTD., matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as KYOWA PHARMACEUTICAL IND.CO.,LTD.,'s capped import value divided by total capped export value for Sertraline across all Indian exporters.
- 5.Verified Records: This page is backed by 45 individual customs records matching KYOWA PHARMACEUTICAL IND.CO.,LTD., importing Sertraline, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 88+ countries, 553+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sertraline Import Data for KYOWA PHARMACEUTICAL IND.CO.,LTD.,
Access order-level details, pricing data, supplier connections, and competitive analysis for KYOWA PHARMACEUTICAL IND.CO.,LTD.,'s Sertraline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
KYOWA PHARMACEUTICAL IND.CO.,LTD.,
Company Profile
Multiple products · $0 total trade · Multiple categories
KYOWA PHARMACEUTICAL IND.CO.,LTD., × Sertraline
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for KYOWA PHARMACEUTICAL IND.CO.,LTD.,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sertraline. For current order-level data, contact TransData Nexus.